BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 17641018)

  • 1. Steady state dendritic cells present parenchymal self-antigen and contribute to, but are not essential for, tolerization of naive and Th1 effector CD4 cells.
    Hagymasi AT; Slaiby AM; Mihalyo MA; Qui HZ; Zammit DJ; Lefrancois L; Adler AJ
    J Immunol; 2007 Aug; 179(3):1524-31. PubMed ID: 17641018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4 cell priming and tolerization are differentially programmed by APCs upon initial engagement.
    Higgins AD; Mihalyo MA; McGary PW; Adler AJ
    J Immunol; 2002 Jun; 168(11):5573-81. PubMed ID: 12023353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cells ameliorate autoimmunity in the CNS by controlling the homeostasis of PD-1 receptor(+) regulatory T cells.
    Yogev N; Frommer F; Lukas D; Kautz-Neu K; Karram K; Ielo D; von Stebut E; Probst HC; van den Broek M; Riethmacher D; Birnberg T; Blank T; Reizis B; Korn T; Wiendl H; Jung S; Prinz M; Kurschus FC; Waisman A
    Immunity; 2012 Aug; 37(2):264-75. PubMed ID: 22902234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fc gamma receptor IIB on dendritic cells enforces peripheral tolerance by inhibiting effector T cell responses.
    Desai DD; Harbers SO; Flores M; Colonna L; Downie MP; Bergtold A; Jung S; Clynes R
    J Immunol; 2007 May; 178(10):6217-26. PubMed ID: 17475849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral dendritic cells mediate antigen-specific tolerance by stimulating TH1 and regulatory CD4+ T cells.
    Mascarell L; Lombardi V; Louise A; Saint-Lu N; Chabre H; Moussu H; Betbeder D; Balazuc AM; Van Overtvelt L; Moingeon P
    J Allergy Clin Immunol; 2008 Sep; 122(3):603-9.e5. PubMed ID: 18774396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both dendritic cells and macrophages can stimulate naive CD8 T cells in vivo to proliferate, develop effector function, and differentiate into memory cells.
    Pozzi LA; Maciaszek JW; Rock KL
    J Immunol; 2005 Aug; 175(4):2071-81. PubMed ID: 16081773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo cyclophosphamide and IL-2 treatment impedes self-antigen-induced effector CD4 cell tolerization: implications for adoptive immunotherapy.
    Mihalyo MA; Doody AD; McAleer JP; Nowak EC; Long M; Yang Y; Adler AJ
    J Immunol; 2004 May; 172(9):5338-45. PubMed ID: 15100273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD8alpha+ and CD11b+ dendritic cell-restricted MHC class II controls Th1 CD4+ T cell immunity.
    Lemos MP; Fan L; Lo D; Laufer TM
    J Immunol; 2003 Nov; 171(10):5077-84. PubMed ID: 14607905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presentation of the self antigen myelin basic protein by dendritic cells leads to experimental autoimmune encephalomyelitis.
    Dittel BN; Visintin I; Merchant RM; Janeway CA
    J Immunol; 1999 Jul; 163(1):32-9. PubMed ID: 10384096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UVB-irradiated dendritic cells are impaired in their APC function and tolerize primed Th1 cells but not naive CD4+ T cells.
    Denfeld RW; Hara H; Tesmann JP; Martin S; Simon JC
    J Leukoc Biol; 2001 Apr; 69(4):548-54. PubMed ID: 11310840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effector CD4 cells are tolerized upon exposure to parenchymal self-antigen.
    Higgins AD; Mihalyo MA; Adler AJ
    J Immunol; 2002 Oct; 169(7):3622-9. PubMed ID: 12244153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the tolerogenic function of steady-state DCs.
    Probst HC; Muth S; Schild H
    Eur J Immunol; 2014 Apr; 44(4):927-33. PubMed ID: 24652744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow-derived dendritic cells reverse the anergic state of CD4+CD25+ T cells without reversing their suppressive function.
    Brinster C; Shevach EM
    J Immunol; 2005 Dec; 175(11):7332-40. PubMed ID: 16301639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fc gamma RIIB regulates nasal and oral tolerance: a role for dendritic cells.
    Samsom JN; van Berkel LA; van Helvoort JM; Unger WW; Jansen W; Thepen T; Mebius RE; Verbeek SS; Kraal G
    J Immunol; 2005 May; 174(9):5279-87. PubMed ID: 15843524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crucial roles of B7-H1 and B7-DC expressed on mesenteric lymph node dendritic cells in the generation of antigen-specific CD4+Foxp3+ regulatory T cells in the establishment of oral tolerance.
    Fukaya T; Takagi H; Sato Y; Sato K; Eizumi K; Taya H; Shin T; Chen L; Dong C; Azuma M; Yagita H; Malissen B; Sato K
    Blood; 2010 Sep; 116(13):2266-76. PubMed ID: 20574047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD11c(+) dendritic cells maintain antigen processing, presentation capabilities, and CD4(+) T-cell priming efficacy under hypercholesterolemic conditions associated with atherosclerosis.
    Packard RR; Maganto-García E; Gotsman I; Tabas I; Libby P; Lichtman AH
    Circ Res; 2008 Oct; 103(9):965-73. PubMed ID: 18832748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerance induction to self antigens by peripheral dendritic cells.
    Lambolez F; Jooss K; Vasseur F; Sarukhan A
    Eur J Immunol; 2002 Sep; 32(9):2588-97. PubMed ID: 12207343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Route of antigen uptake differentially impacts presentation by dendritic cells and activated monocytes.
    Kamphorst AO; Guermonprez P; Dudziak D; Nussenzweig MC
    J Immunol; 2010 Sep; 185(6):3426-35. PubMed ID: 20729332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A CD40/CD40L feedback loop drives the breakdown of CD8(+) T-cell tolerance following depletion of suppressive CD4(+) T cells.
    Muth S; Schütze K; Hain T; Yagita H; Schild H; Probst HC
    Eur J Immunol; 2014 Apr; 44(4):1099-107. PubMed ID: 24420080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen presentation by an immature myeloid dendritic cell line does not cause CTL deletion in vivo, but generates CD8+ central memory-like T cells that can be rescued for full effector function.
    Dumortier H; van Mierlo GJ; Egan D; van Ewijk W; Toes RE; Offringa R; Melief CJ
    J Immunol; 2005 Jul; 175(2):855-63. PubMed ID: 16002683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.